Related Experiment Video
Updated: Aug 9, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
International study on low-grade primary central nervous system lymphoma
Kristoph Jahnke1, Agnieszka Korfel, Brian Patrick O'Neill
1Department of Hematology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. kristophe.jahnke@charite.de
Annals of Neurology
|April 6, 2006
Summary
Low-grade primary central nervous system lymphoma (LG-PCNSL) presents uniquely and has a better prognosis than high-grade types. Older age (60+) negatively impacts survival in LG-PCNSL patients.
Area of Science:
- Neuro-oncology
- Hematology
- Clinical Neurology
Background:
- Low-grade primary central nervous system lymphoma (LG-PCNSL) is a rare subtype of brain tumor.
- Understanding its distinct clinical characteristics is crucial for effective management.
Purpose of the Study:
- To characterize the clinical presentation, disease course, and patient outcomes for LG-PCNSL.
- To identify prognostic factors influencing survival in LG-PCNSL.
Main Methods:
- Retrospective analysis of 40 LG-PCNSL cases from 18 cancer centers across 5 countries.
- Data collection included patient demographics, tumor location, treatment modalities, and survival metrics.
Main Results:
- LG-PCNSL most commonly involved cerebral hemispheres or deep brain structures (37/40 patients).
- Median progression-free survival was 61.5 months, disease-specific survival was 130 months, and overall survival was 79 months.
- Age 60 years or older was significantly associated with shorter progression-free, disease-specific, and overall survival in multivariate analysis.
Conclusions:
- LG-PCNSL exhibits distinct pathological, clinical, and radiological features compared to high-grade PCNSL.
- LG-PCNSL demonstrates a more favorable long-term outcome than typical PCNSL.
- Advanced age (≥60 years) is a significant negative prognostic factor for survival in LG-PCNSL.
